Fresenius | FRE - Ebit

Stock Price
51.72
Daily Change
-0.34 -0.65%
Monthly
7.59%
Yearly
41.54%
Q1 Forecast
50.68

Fresenius reported EUR574M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Akzo Nobel EUR 217M 80M Dec/2025
Alcon AG USD 334M 84M Sep/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
BASF EUR 493M 334M Sep/2025
Bayer EUR -399M 363M Sep/2025
Beiersdorf EUR 816M 370M Jun/2025
DaVita Healthcare Partners USD 584.2M 124.84M Dec/2025
Demant DKK 2.07B 201M Dec/2025
E.ON EUR 709M 548M Sep/2025
Essilor EUR 1.38B 626M Dec/2025
Fresenius EUR 574M 14M Sep/2025
Fresenius Medical Care EUR 449.94M 18.94M Sep/2025
Getinge SEK 2.02B 1.2B Dec/2024
Givaudan CHF 756M 221M Jun/2024
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GN Store Nord DKK 570M 230M Dec/2025
GRIFOLS EUR 352.11M 20.18M Sep/2025
Hikma Pharmaceutical USD 317M 85M Dec/2024
Lonza CHF 673M 54M Jun/2025
Merck EUR 1.21B 180M Sep/2025
Novartis USD -9.19B 13.87B Jun/2025
Philips EUR 719M 390M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
RWE EUR 1.43B 791M Sep/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Smith & Nephew USD 440M 50M Dec/2025